Q2 FY2026 EarningsQ2 FY2026 results showed a slight top-line beat but significant bottom-line pressure: revenue of $848.9M beat consensus by 2.24%, yet GAAP EPS of -$0.12 missed the expected -$0.07. While same-facility revenue grew 5.0% YoY driven by pricing (+4.8% per case), Adjusted EBITDA declined 2.9% YoY to $125.2M. Full-year FY26 guidance was reaffirmed, but the pending Idaho Falls divestiture and rising interest expenses remain key focal points for the second half.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Surgery Partners(SGRY) the Revenue is 848.9 M (+2.75%), Beat estimate;the EBIT is 85.9 M (-3.16%), Miss estimate;the EPS is -0.12 (-500%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.85B2.75%
0.83B0.50%
+0.02B2.25%
EBITMiss expectations
0.09B3.16%
0.09B4.21%
-0.01B7.37%
EPSMiss expectations
-0.12500.00%
-0.0687243.55%
-0.0513256.45%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf